Press Release

Egypt Cardiovascular Devices Market is expected to grow at a CAGR of 7.12% through 2029

Rising incidence of cardiovascular disorders are expected to drive the growth of the Egypt Cardiovascular Devices Market in the forecast period, 2025-2029.


According to TechSci Research report, “Egypt Cardiovascular Devices- By Region, Competition Forecast and Opportunities, 2019-2029F”, the Egypt Cardiovascular Devices Market was valued at USD 140.02 Million in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.12% through 2029. The main causes are the growing prevalence of cardiovascular diseases, government initiatives, technological advancements, aging population, and increase in healthcare spending.

The rising demand for preventive healthcare and the increasing awareness of the benefits of early diagnosis and monitoring of cardiovascular diseases are also driving the market. The market is expected to continue to grow in the coming years, with the diagnostic and monitoring devices segment projected to dominate the market due to the increasing need for early diagnosis and monitoring of cardiovascular diseases.

The COVID-19 pandemic has had an impact on the Egypt cardiovascular devices market, as it has on the global healthcare industry. Due to the pandemic, many elective surgeries, including cardiovascular procedures, were postponed or cancelled in 2020, leading to a temporary decline in the market. The supply chain disruptions and manufacturing delays due to the pandemic also affected the market. However, as the pandemic situation improves and healthcare services return to normal, the market is expected to recover and continue its growth trajectory. Moreover, the pandemic has increased awareness about the importance of cardiovascular health and the need for early diagnosis and monitoring of cardiovascular diseases, which may further drive the demand for cardiovascular devices in the future.


Browse over XX market data Figures spread through 70 Pages and an in-depth TOC on "Egypt Cardiovascular Devices Market


The Egypt Cardiovascular Devices Market can be segmented by type, application, end user, source, region.

In terms of application, the market can be divided into Coronary Artery Disease, Cardiac Arrhythmia, Heart Failure, and Others. The Coronary Artery Disease (CAD) segment is expected to dominate the Egypt cardiovascular devices market in the forecast period because CAD is the most common type of cardiovascular disease in Egypt, accounting for a significant proportion of the total burden of cardiovascular diseases in the country. As such, the demand for devices used in the diagnosis and treatment of CAD, such as stents, catheters, and balloon dilatation devices, is expected to be high. Furthermore, there is a growing trend towards minimally invasive procedures for the treatment of CAD, which has driven the demand for devices used in these procedures. These devices are preferred over traditional surgical procedures as they are less invasive and have shorter recovery times, resulting in improved patient outcomes.


Major companies operating in Egypt Cardiovascular Devices Market include:

  • Siemens Healthineers Egypt
  • PHILIPS Egypt
  • Medtronic Egypt LLC
  • Abbott Egypt
  • Roche Egypt LLC
  • Boston Scientific
  • Shenzhen Mindray Bio-Medical Electronics
  • ACS Diagnostics
  • GE Healthcare Egypt
  • Koninklijke Philips N.V. (Biotelemetry)


Download Free Sample Report

Customers can also request for 10% free customization on this report.


“The cardiovascular devices market in Egypt has been growing steadily in recent years, driven by factors such as an aging population, an increasing prevalence of cardiovascular disease, and an improving healthcare infrastructure. The market encompasses a range of products, including diagnostic and monitoring devices, therapeutic devices, and implantable devices. While the market is dominated by multinational companies, there is also a growing presence of local manufacturers. However, challenges such as regulatory barriers, inadequate reimbursement systems, and limited healthcare resources in some areas of the country continue to constrain the growth of the market. Nonetheless, with ongoing investments in the healthcare sector and increasing awareness of the importance of cardiovascular health, the cardiovascular devices market in Egypt is expected to continue to grow in the coming years.” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based global management consulting firm.

“Egypt Cardiovascular Devices Market By Type (Diagnostic & Monitoring Devices v/s Surgical Devices), By Application (Coronary Artery Disease, Cardiac Arrhythmia, Heart Failure, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Others), By Source (Domestic v/s Import), By Region, Competition Forecast & Opportunities, 2028,” has evaluated the future growth potential of Egypt Cardiovascular Devices Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Egypt Cardiovascular Devices Market.


Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com

Relevant News